{"entity":{"type":"insider","cik":"0001593440","url":"/insider/0001593440","json_url":"/insider/0001593440.json","name":"Apple Tree Partners IV, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2019-06-21","last":"2020-11-25","span_basis":"filed_date"},"name_variants":[{"name":"Apple Tree Partners IV, L.P.","source":"filing","n_filings":4,"first_seen":"2019-06-21","last_seen":"2020-11-25"}],"transactions":[{"id":2383173,"accession":"0001209191-20-060542","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-060542","line_url":"/filing/0001209191-20-060542#line-1","is_derivative":false,"issuer_cik":"0001593440","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001593440","owner_cik":null,"owner_name":"Apple Tree Partners IV, L.P.; ATP III GP, Ltd.","owner_display_name":"Apple Tree Partners IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":375000.0,"shares_display":"375,000","price_per_share":39.0,"price_display":"39.00","price_state":"stated","total_value":14625000.0,"total_display":"14,625,000.00","total_whole":"14,625,000","shares_owned_after":17161713.0,"shares_owned_after_display":"17,161,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-24","filed_date":"2020-11-25","scope":"insider"},{"id":2105728,"accession":"0001104659-20-083455","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-083455","line_url":"/filing/0001104659-20-083455#line-1","is_derivative":false,"issuer_cik":"0001593440","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001593440","owner_cik":null,"owner_name":"Apple Tree Partners IV, L.P.; ATP III GP, Ltd.","owner_display_name":"Apple Tree Partners IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":415000.0,"shares_display":"415,000","price_per_share":36.0,"price_display":"36.00","price_state":"stated","total_value":14940000.0,"total_display":"14,940,000.00","total_whole":"14,940,000","shares_owned_after":5830203.0,"shares_owned_after_display":"5,830,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-10","filed_date":"2020-07-14","scope":"insider"},{"id":8145916,"accession":"0001104659-19-037457","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-037457","line_url":"/filing/0001104659-19-037457#line-3","is_derivative":false,"issuer_cik":"0001593440","issuer_name":"Akero Therapeutics, Inc.","issuer_ticker":"AKRO","issuer_name_source":null,"issuer_url":"/issuer/0001593440","owner_cik":null,"owner_name":"ATP III GP, Ltd.; Apple Tree Partners IV, L.P.","owner_display_name":"ATP III GP, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900000.0,"shares_display":"900,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":14400000.0,"total_display":"14,400,000.00","total_whole":"14,400,000","shares_owned_after":5415203.0,"shares_owned_after_display":"5,415,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-24","filed_date":"2019-06-25","scope":"insider"},{"id":7791368,"accession":"0001567619-19-013838","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001567619-19-013838","line_url":"/filing/0001567619-19-013838#line-4","is_derivative":false,"issuer_cik":"0001593440","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001593440","owner_cik":null,"owner_name":"Apple Tree Partners IV, L.P.; ATP III GP, Ltd.","owner_display_name":"Apple Tree Partners IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1388889.0,"shares_display":"1,388,889","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":25000002.0,"total_display":"25,000,002.00","total_whole":"25,000,002","shares_owned_after":16786713.0,"shares_owned_after_display":"16,786,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-21","filed_date":"2019-06-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001623526","name":"Stoke Therapeutics, Inc.","url":"/issuer/0001623526","role":"Ten percent owner","n_filings":2,"first_seen":"2019-06-21","last_seen":"2020-11-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001744659","name":"Akero Therapeutics, Inc.","url":"/issuer/0001744659","role":"Ten percent owner","n_filings":2,"first_seen":"2019-06-25","last_seen":"2020-07-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001593440","retrieved_at":"2026-08-25T09:08:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}